Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |